Ranibizumab ophthalmic and Viracept (Nelfinavir Oral Powder)
Determining the interaction of Ranibizumab ophthalmic and Viracept (Nelfinavir Oral Powder) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: nelfinavir
Brand name: Viracept
Synonyms: Viracept
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab ophthalmic-Viracept (Nelfinavir Tablets)
- Ranibizumab ophthalmic-Viramune
- Ranibizumab ophthalmic-Viramune (Nevirapine Oral Suspension)
- Ranibizumab ophthalmic-Viramune (Nevirapine Tablets)
- Ranibizumab ophthalmic-Viramune O/S
- Ranibizumab ophthalmic-Viramune Suspension
- Viracept (Nelfinavir Oral Powder)-Ranitidine
- Viracept (Nelfinavir Oral Powder)-Ranitidine Capsule
- Viracept (Nelfinavir Oral Powder)-Ranitidine Hydrochloride
- Viracept (Nelfinavir Oral Powder)-Ranitidine Injection
- Viracept (Nelfinavir Oral Powder)-Ranitidine Suspension
- Viracept (Nelfinavir Oral Powder)-Ranitidine Syrup